Nymox Pharmaceutical
NYMX
#9648
Rank
C$25.66 M
Marketcap
Country
$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.91 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$9.18 Million, an increase over its 2021 earnings that were of -C$17.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.91 Million-68.33%
2022 -C$9.18 Million-47.71%
2021 -C$17.56 Million6.61%
2020 -C$16.47 Million-10.91%
2019 -C$18.48 Million24.24%
2018 -C$14.88 Million-20.03%
2017 -C$18.6 Million2.71%
2016 -C$18.11 Million-63.86%
2015 -C$50.11 Million674.44%
2014 -C$6.47 Million-6.11%
2013 -C$6.9 Million-35.66%
2012 -C$10.72 Million-20.76%
2011 -C$13.52 Million38.33%
2010 -C$9.78 Million35.59%
2009 -C$7.21 Million11.8%
2008 -C$6.45 Million-12.94%
2007 -C$7.41 Million8.85%
2006 -C$6.81 Million36.5%
2005 -C$4.99 Million-4.4%
2004 -C$5.22 Million-14.58%
2003 -C$6.11 Million
2001 -C$4.48 Million-20.54%
2000 -C$5.64 Million21.72%
1999 -C$4.63 Million-25.56%
1998 -C$6.22 Million101.3%
1997 -C$3.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$9.53 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$1.71 Billion 55,985.15%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.56 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.27 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.86 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA